Results 251 to 260 of about 236,526 (353)

P361 Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease [PDF]

open access: bronze
Hye Kyung Hyun   +13 more
openalex   +1 more source

BuShenKangShuai Tablet Alleviates Hepatic Steatosis via Improving Liver Adiponectin Resistance in ApoE-/- Mice [PDF]

open access: hybrid, 2019
Shuchao Pang   +7 more
openalex   +1 more source

Link between gut‐microbiome derived metabolite and shared gene‐effects with hepatic steatosis and fibrosis in NAFLD

open access: yesHepatology, 2018
Cyrielle Caussy   +15 more
semanticscholar   +1 more source

Genetic variants underlying precancerous conditions of hepatocellular carcinoma

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Hepatocellular carcinoma (HCC) is the most common form of liver cancer, accounting for 80% of cases worldwide. While chronic hepatitis B and C infections remain primary risk factors, emerging evidence highlights the increasing contributions of metabolic dysfunction‐associated steatotic liver disease (MASLD) and alcohol‐associated liver disease
Jonathan Jaime G. Guerrero   +7 more
wiley   +1 more source

Machine Learning-Based Biomarker Identification for Early Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease. [PDF]

open access: yesJ Clin Endocrinol Metab
Boullion J   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy